Beta
184943

THE POSSIBLE PROTECTIVE EFFECTS OF NIGELLA SATIVA CRUDE SEEDS ON GENTAMICIN INDUCED NEPHROTOXICITY IN UNILATERAL NEPHROECTOM1ZED RATS

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

-

Abstract

Nigella sativa seed is widely used as general tonic , it was suggested to have a general protective roles. Twenty four white male albino rats were divided into four equal groups. The first group was exposed to sham operation and received saline through an oro-gastric tube for 15 consecutive days and kept as control. The other groups were subjected to unilateral nephroectomy. The second group was given suspension of crushed seeds of Nigella sativa , 2gm / kg B.W. orally daily for 15 consecutive days. The third group was injected intraperitoneally (i.p.) by gentamicin in a dose of 30 mg/kg B.W. daily for the same period. The fourth group was injected (i.p) by 30 mg/kg B.W. gentamicin i.p., in compination with 2gm /kg B.W. suspension of crushed seed of Nigella sativa orally daily for the same period. Changes in blood pressure, heart rate, blood urea and serum creatinine were recorded. The histopathologicial changes in kidneys were also demonstrated. The results of this study , revealed that, gentamicin alone showed a significant increase in blood pressure, blood urea, and serum creatinine, there is no significant changes in the group given Nigella sativa alone. On the other hand, insignificant changes were recorded in the same parameters, in the group given gentamicin in combination with suspension of crushed seeds of Nigella sativa. Histpathological studies of the kidney, showed tubular degeneration, tubular necrosis, interstitial haemorrhage and basement membrane distortion with gentamicin. On the other hand no histopathological changes were recorded in gentamicin and Nigella sativa treated group. These changes supported our findings. These results suggested that Nigella sativa seeds and their constituents did not produce deleterous effects on kidney tissues and function, but prevented the nephrotoxic manifestations of gentamicin.

DOI

10.21608/zjps.1997.184943

Authors

First Name

Mohamed

Last Name

Farrag

MiddleName

-

Affiliation

Department of Pharmacology, Zagazig and Benha Faculty of Medicine, Zagazig University, Egypt

Email

mohamed.farrag@yahoo.com

City

-

Orcid

-

First Name

Ahmed

Last Name

Mohamed

MiddleName

-

Affiliation

Department of Pharmacology, Zagazig and Benha Faculty of Medicine, Zagazig University, Egypt

Email

ahmed.mohamed@yahoo.com

City

-

Orcid

-

First Name

Mary

Last Name

Boutrus

MiddleName

-

Affiliation

Department of Pharmacology, Zagazig and Benha Faculty of Medicine, Zagazig University, Egypt

Email

mary.boutrus@yahoo.com

City

-

Orcid

-

First Name

Yehia

Last Name

El-Alfy

MiddleName

-

Affiliation

Department of Pathology, Zagazig and Benha Faculty of Medicine, Zagazig University, Egypt

Email

yehia.el-alfy@yahoo.com

City

-

Orcid

-

Volume

6

Article Issue

2

Related Issue

24768

Issue Date

1997-12-01

Receive Date

1997-09-04

Publish Date

1997-12-01

Page Start

44

Page End

53

Print ISSN

1110-5089

Online ISSN

2356-9786

Link

https://zjps.journals.ekb.eg/article_184943.html

Detail API

https://zjps.journals.ekb.eg/service?article_code=184943

Order

9

Type

Original Article

Type Code

862

Publication Type

Journal

Publication Title

Zagazig Journal of Pharmaceutical Sciences

Publication Link

https://zjps.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023